{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:26Z","timestamp":1791409886764,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010002","name":"Executive Yuan Republic of China Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007844","name":"National Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2320-B-110-009-MY3"],"award-info":[{"award-number":["NSTC 113-2320-B-110-009-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110293","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:02:17Z","timestamp":1785250937000},"page":"110293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of hydrazone derivatives as novel STAT3 antagonists against pancreatic and colorectal cancers"],"prefix":"10.1016","volume":"181","author":[{"given":"Hsin-Yu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hua","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chang","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110293_bb0005","series-title":"Clinical Features, Treatment, and Prognosis of SGLT2 Inhibitors Induced Acute Pancreatitis","first-page":"1253","author":"Li","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110293_bb0010","series-title":"Risk factors for pancreatic cancer: underlying mechanisms and potential targets","first-page":"1","volume":"4","author":"Kolodecik","year":"2014"},{"key":"10.1016\/j.bioorg.2026.110293_bb0015","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic Cancer\u00a0: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110293_bb0020","author":"Therapy","year":"2024","journal-title":"Signaling Pathways Involved in Colorectal Cancer\u00a0: Pathogenesis and Targeted Therapy."},{"key":"10.1016\/j.bioorg.2026.110293_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","article-title":"Colorectal Cancer incidence trends in younger versus older adults\u00a0: an analysis of population-based Cancer registry data","volume":"26","author":"Sung","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bioorg.2026.110293_bb0030","first-page":"2638","article-title":"Interaction between Linc01615 and MiR-491-5p regulates the survival and metastasis of colorectal","volume":"9","author":"Xiao","year":"2020","journal-title":"Cancer Cells"},{"key":"10.1016\/j.bioorg.2026.110293_bb0035","series-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K \/ AKT \/ MTOR signaling pathway","first-page":"1","volume":"13","author":"Tong","year":"2022"},{"key":"10.1016\/j.bioorg.2026.110293_bb0040","first-page":"1","article-title":"Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer","author":"Zhu","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2026.110293_bb0045","article-title":"Exploring the differences in the tumor microenvironment and Immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status","volume":"4","author":"Faber","year":"2024","journal-title":"ESMO Gastrointest. Oncol."},{"key":"10.1016\/j.bioorg.2026.110293_bb0050","series-title":"Targeting STAT3 by a small molecule suppresses pancreatic cancer progression","first-page":"1440","author":"Chen","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110293_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116010","article-title":"Article a STAT3 \/ integrin axis accelerates pancreatic cancer initiation and progression Ll a STAT3 \/ integrin axis accelerates","volume":"44","author":"Campos","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2026.110293_bb0060","series-title":"Targeting STAT3 Signaling Pathway in Colorectal Cancer","author":"Gargalionis","year":"2021"},{"key":"10.1016\/j.bioorg.2026.110293_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117241","article-title":"Revisiting the development of small molecular inhibitors that directly target the signal transducer and activator of transcription 3 (STAT3) domains","volume":"242","author":"Shih","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2026.110293_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2020.11.032","article-title":"Role of STAT3 Signaling transduction pathways in Cancer stem cell-associated chemoresistance","author":"Shih","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.110293_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108118","article-title":"The role of the STAT3 Signaling transduction pathways in Radioresistance","volume":"234","author":"Shih","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2026.110293_bb0080","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: a small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110293_bb0085","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1073\/pnas.0609757104","article-title":"Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity","volume":"104","author":"Siddiquee","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110293_bb0090","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/cb500071v","article-title":"A small molecule compound targeting STAT3 DNA-binding domain inhibits cancer cell proliferation, migration, and invasion","volume":"9","author":"Huang","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110293_bb0095","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-15-0003","article-title":"Applying small molecule signal transducer and activator of Trancription-3 (STAT3) protein inhibitors as pancreatic cancer therapeutics","author":"Arpin","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2026.110293_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0170709","article-title":"Inhibition of STAT3 by anticancer drug Bendamustine","volume":"12","author":"Iwamoto","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2026.110293_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17600-x","article-title":"Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in erlotinib-resistant lung Cancer cells","volume":"7","author":"Lis","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110293_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178844","article-title":"Identification of novel small molecules that inhibit STAT3-dependent transcription and function","volume":"12","author":"Kolosenko","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2026.110293_bb0115","series-title":"Bt354 as a new STAT3 signaling pathway inhibitor against triple negative breast cancer breast cancer","volume":"2330","author":"Chen","year":"2018"},{"key":"10.1016\/j.bioorg.2026.110293_bb0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/CAD.0000000000000605","article-title":"A novel small molecular STAT3 inhibitor, 5Br-6b, induces apoptosis and inhibits migration in colorectal Cancer cells","volume":"29","author":"Liu","year":"2018","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bioorg.2026.110293_bb0125","series-title":"STAT3 signaling pathway in health and disease","author":"Samad","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110293_bb0130","first-page":"1","article-title":"Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery","author":"Hu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110293_bb0135","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00044-026-03545-2","article-title":"Discovery of phenylacetamide derivatives as novel STAT3 antagonists","author":"Shih","year":"2026","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110293_bb0140","doi-asserted-by":"crossref","first-page":"32690","DOI":"10.18632\/oncotarget.26013","article-title":"A high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3)","volume":"9","author":"Shih","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.110293_bb0145","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ml100146z","article-title":"Identification of Niclosamide as a new small-molecule inhibitor of the STAT3 Signaling pathway","volume":"1","author":"Ren","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110293_bb0150","doi-asserted-by":"crossref","first-page":"11528","DOI":"10.1074\/jbc.M413930200","article-title":"Activation of Stat3 sequence-specific DNA binding and transcription by P300\/CREB-binding protein-mediated acetylation","volume":"280","author":"Wang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110293_bb0155","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/ci034243x","article-title":"ESOL: estimating aqueous solubility directly from molecular structure","volume":"44","author":"Delaney","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.bioorg.2026.110293_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118305","article-title":"Anticancer activity of hydrazones in the last quinquennial period: a special emphasis on various enzyme targets and SAR","volume":"302","author":"Charan","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110293_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104971","article-title":"Nitrofurazone repurposing towards design and synthesis of novel apoptotic-dependent anticancer and antimicrobial agents: biological evaluation, kinetic studies and molecular Modeling","volume":"113","author":"El-Wakil","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110293_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgh3.12843","article-title":"kornManagement of helicobacter pylori infection","volume":"7","author":"Aumpan","year":"2023","journal-title":"JGH Open"},{"key":"10.1016\/j.bioorg.2026.110293_bb0175","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1093\/jac\/dkad287","article-title":"Nitrofurantoin: what is the evidence for current UK guidance?","volume":"78","author":"Kashouris","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2026.110293_bb0180","first-page":"227","article-title":"Levosimendan: current data, clinical use and future development","volume":"5","author":"Nieminen","year":"2013","journal-title":"Hear. lung Vessel."},{"key":"10.1016\/j.bioorg.2026.110293_bb0185","first-page":"1","article-title":"Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo","author":"Huang","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110293_bb0190","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1021\/acscentsci.3c01440","article-title":"Discovery of the highly selective and potent STAT3 inhibitor for pancreatic Cancer treatment","volume":"10","author":"Chen","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2026.110293_bb0195","series-title":"STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis","first-page":"5020","volume":"71","author":"Corcoran","year":"2011"},{"key":"10.1016\/j.bioorg.2026.110293_bb0200","doi-asserted-by":"crossref","first-page":"23838","DOI":"10.1074\/jbc.M115.657833","article-title":"The mutant KRAS gene up-regulates BCL-XL protein via STAT3 to confer apoptosis resistance that is reversed by BIM protein induction and BCL-XL antagonism","volume":"290","author":"Zaanan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110293_bb0205","first-page":"1","article-title":"Niraparib-induced STAT3 inhibition increases its antitumor effects","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.110293_bb0210","doi-asserted-by":"crossref","first-page":"15487","DOI":"10.1021\/acs.jmedchem.2c01554","article-title":"Discovery of a highly potent and orally bioavailable STAT3 dual phosphorylation inhibitor for pancreatic Cancer treatment","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110293_bb0215","series-title":"Mechanisms of disease: oncogene addiction \u2014 a rationale for molecular targeting in cancer therapy the concept of oncogene addiction review criteria","first-page":"448","volume":"3","author":"Weinstein","year":"2006"},{"key":"10.1016\/j.bioorg.2026.110293_bb0220","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cell.2017.01.020","article-title":"Article KRAS allelic imbalance enhances fitness and modulates MAP kinase dependence in cancer article KRAS allelic imbalance enhances fitness and modulates MAP kinase dependence in cancer","volume":"168","author":"Burgess","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.110293_bb0225","series-title":"KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo","first-page":"1","author":"Najumudeen","year":"2024"},{"key":"10.1016\/j.bioorg.2026.110293_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158813","article-title":"Stellettin B-induced oral cancer cell death via endoplasmic reticulum stress\u2013mitochondrial apoptotic and autophagic signaling pathway","volume":"23","author":"Kuo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110293_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10121883","article-title":"Pardaxin activates excessive mitophagy and mitochondria-mediated apoptosis in human ovarian Cancer by inducing reactive oxygen species","author":"Chen","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioorg.2026.110293_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114359","article-title":"Isoaaptamine increases ROS levels causing autophagy and mitochondria-mediated apoptosis in glioblastoma multiforme cells","volume":"160","author":"Wen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.110293_bb0245","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110293_bb0250","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110293_bb0255","series-title":"San Diego, CA","author":"Syst\u00e8mes","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110293_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:52Z","timestamp":1791407392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"alternative-id":["S0045206826008291"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110293","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of hydrazone derivatives as novel STAT3 antagonists against pancreatic and colorectal cancers","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110293"}}